Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Global Trends in R&D 2024

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE

Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
WORKING AT IQVIA

Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.

LEARN MORE
LIFE AT IQVIA

Careers, culture and everything in between. Find out what’s going on right here, right now.

LEARN MORE

WE’RE HIRING

"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

SEARCH JOBS
MAIN/Contact Us
Contact Us/
Scientific Poster
IQVIA Publications in ASCO20 Virtual Scientific Program
May 21, 2020
  • Library
  • IQVIA Publications in ASCO20 Virtual Scientific Program
As the American Society of Oncology (ASCO) 2020 annual meeting moved to a virtual format, IQVIA’s oncology experts contributed to several publications across multiple topics and indications.  

Featured Abstracts

What are the challenges for building real world comparative cohorts in oncology?

Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement

IQVIA Authors
Nikita Jeswani, Amanda McDonell, Finlay MacDougall, Jeff Paul Hodge

Leveraging real world data and AIML to inform smart patient care in oncology

Abstract in ASCO20 Virtual Scientific Program: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

IQVIA Authors
Li Zhou, Rob Steen, Lynn Lu

Patient trial matching using pseudo-siamese network

Abstract in ASCO20 Virtual Scientific Program: Care Delivery and Regulatory Policy

IQVIA Authors
Cao Xiao, Junyi Gao, Lucas Glass, Jimeng Sun

See below for more ASCO20 abstracts from IQVIA authors.  

MSI/MMR test usage and checkpoint inhibitor practices in Europe.

Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement

AUTHORS

Bradley Smith, Jeffrey Hodge, Caroline Anger, Fil Manuguid, Kriti Jindal; IQVIA, Marblehead, MA; IQVIA, Durham, NC; IQVIA, London, United Kingdom

View Abstract


Real-world clinical and economic burden associated with hospitalization in metastatic triple-negative (ER-/PR-/HER2-) breast cancer.

Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement

AUTHORS

Amie Tan, Xu Han, Aimee Near, Jenny Tse, Luciana Preger; Genentech, Inc., South San Francisco, CA; IQVIA, Durham, NC

VIEW ABSTRACT


Trends in immunotherapy use in patients with advanced non-small cell lung cancer (aNSCLC) patients: Analysis of real-world data.

Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement

AUTHORS

Lawrence H. Kushi, Laura Lasiter, Andrew J. Belli, Marley Boyd, Suanna S. Bruinooge, Jennifer Christian, Elizabeth Garrett-Mayer, Eric Hansen, Rebecca Honnold, Ruth Pe Benito, Yanina Natanzon, Lori Sakoda, Donna R. R Rivera, Whitney Rhodes, Nicholas J. Robert, Elad Sharon, Connor Sweetnam, Joseph Wagner, Mark S. Walker, Jeff Allen; Kaiser Permanente, Oakland, CA; Friends of Cancer Research, Washington, DC; COTA, Inc., New York, NY; McKesson Life Sciences, The Woodlands, TX; American Society of Clinical Oncology, Alexandria, VA; IQVIA, Research Triangle Park, NC; Tempus Labs, Chicago; Tempus, Chicago, IL; Syapse, San Francisco, CA; Kaiser Permanente Northern California, Division of Research, Oakland, CA; National Cancer Institute, Rockville, MD; Concerto HealthAI, Memphis, TN; 10101 Woodloch Forest, The Woodlands, TX; National Cancer Institute, Bethesda, MD; Syapse Inc., San Francisco, CA; IQVIA, Plymouth Meeting, PA; ACORN Research LLC, Memphis, TN

VIEW ABSTRACT 


Overall survival (OS) in advanced non-small cell lung cancer (aNSCLC) patients treated with frontline chemotherapy or immunotherapy by comorbidity: A real-world data (RWD) collaboration.

Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement

AUTHOR(S)

Donna R. R Rivera, Laura Lasiter, Jennifer Christian, Lindsey Enewold, Janet L. Espirito, Eric Hansen, Henry J. Henk, Lawrence H. Kushi, Daniel Lane, Yanina Natanzon, Ruth Pe Benito, Erik Rasmussen, Nicholas J. Robert, Mark Stewart, Connor Sweetnam, Olga Tymejczyk, Emily Valice, Joseph Wagner, Alia Zander, Jeff Allen; National Cancer Institute, Rockville, MD; Friends of Cancer Research, Washington, DC; IQVIA, Research Triangle Park, NC; National Cancer Institute, Bethesda, MD; McKesson Life Sciences, The Woodlands, TX; COTA, Inc., New York, NY; OptumLabs, Shakopee, MN; Kaiser Permanente, Oakland, CA; COTA Healthcare, Boston, MA; Syapse, San Francisco, CA; Tempus, Chicago, IL; Flatiron Health, New York, NY; 10101 Woodloch Forest, The Woodlands, TX; Syapse Inc., San Francisco, CA; Kaiser Permanente Division of Research, Oakland, CA; IQVIA, Plymouth Meeting, PA

VIEW ABSTRACT 


Adverse event and outcome patterns in patients with advanced multiple myeloma in the United States.

Abstract in ASCO20 Virtual Scientific Program: Hematologic Malignancies—Plasma Cell Dyscrasia

AUTHORS

Joshua Ryan Richter, Jason Yeaw, Drishti Shah, Ruthwik Anupindi, Suneel Kudaravalli, Stojan Zavisic; The Tisch Cancer Institute/Icahn School of Medicine at Mount Sinai, New York, NY; IQVIA, San Francisco; IQVIA, Falls Church, VA; Oncopeptides, Mountain View, CA; Oncopeptides AB, Stockholm, Sweden

VIEW ABSTRACT


Burden of relapsed/refractory (RR) acute myeloid leukemia.

Abstract in ASCO20 Virtual Scientific Program: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

AUTHORS

Sumeet Panjabi, Dionne M. Hines, Catherine Balderston McGuiness, Emre Yucel, Steven Yea, Zachariah McIver, Rolin L Wade; Amgen, Inc., South San Francisco, CA; IQVIA, Plymouth Meeting, PA; Amgen, Inc, Thousand Oaks, CA

VIEW ABSTRACT


A retrospective analysis of CDK4/6 inhibitors among adult female patients with metastatic breast cancer.

Abstract in ASCO20 Virtual Scientific Program: Breast Cancer—Metastatic

AUTHORS

Silvia Comis, Thenmozhi Kandasamy, Alysa J Perrin, Kelley Kent, Mahendra Dulawat, Arun Chhikara, Nitish Ranjan; IQVIA, Milan, Italy; IQVIA, Inc., Durham, NC

VIEW ABSTRACT


Prognostic factors impacting survival in early HER2-positive breast cancer (BC): Results from a 1,142 patients database study.

Abstract in ASCO20 Virtual Scientific Program: Breast Cancer - Local/Regional/Adjuvant

AUTHORS

Roberto Hegg, Andre Mattar, Maurício Rocha, Renato Watanabe Oliveira, Guilherme Silva Julian, Luiz Henrique Gebrim; Hospital Pérola Byington, São Paulo, Brazil; Roche Brazil, São Paulo, Brazil; IQVIA, São Paulo, Brazil

VIEW ABSTRACT


Comparative effectiveness of immune-checkpoint inhibitors as first-line treatment for advanced nonsquamous non-small cell lung cancer patients: A network meta-analysis and a systematic review.

Abstract in ASCO20 Virtual Scientific Program: Lung Cancer—Non-Small Cell Metastatic

AUTHORS

Roberto Jorge Bitton, Natalia Jacob, Juan Manuel Carrera, Ezequiel Cayetano Perez; IQVIA, Buenos Aires, Argentina; Quintiles, Buenos Aires, Argentina

VIEW ABSTRACT
Contact Us